STRS Ohio’s Maravai LifeSciences MRVI Stock Holding History

STRS Ohio’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$465K	Hold	164,300	–	–	﹤0.01%	1122
2025 Q4	$534K	Sell	164,300 -44,500	-21%	-$150K	﹤0.01%	1044
2025 Q3	$599K	Hold	208,800	–	–	﹤0.01%	936
2025 Q2	$503K	Buy	208,800 +14,800	+8%	+$31.1K	﹤0.01%	1294
2025 Q1	$429K	Buy	194,000 +84,200	+77%	+$333K	﹤0.01%	1271
2024 Q4	$598K	Buy	109,800 +29,900	+37%	+$192K	﹤0.01%	1072
2024 Q3	$664K	Sell	79,900 -5,900	-7%	-$51K	﹤0.01%	1084
2024 Q2	$614K	Buy	+85,800	New	+$741K	﹤0.01%	1087
2022 Q1	–	Sell	-180,586	Closed	-$7.57M	–	2213
2021 Q4	$7.57M	Buy	180,586 +29,586	+20%	+$1.2M	0.03%	437
2021 Q3	$7.41M	Sell	151,000 -26,600	-15%	-$1.3M	0.03%	445
2021 Q2	$7.41M	Buy	177,600 +18,900	+12%	+$733K	0.03%	444
2021 Q1	$5.66M	Buy	158,700 +52,200	+49%	+$1.73M	0.02%	478
2020 Q4	$2.99M	Buy	+106,500	New	+$2.97M	0.01%	591

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

STRS Ohio's MRVI Position: Q1 2026 in Review

STRS Ohio held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 164,300 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

STRS Ohio first reported a position in MRVI in Q4 2020 and has held it in 13 quarters since. The position peaked at $7.57M in Q4 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

STRS Ohio held 164,300 shares of Maravai LifeSciences worth $465K as of Q1 2026.
STRS Ohio left its Maravai LifeSciences share count unchanged in Q1 2026.
Maravai LifeSciences made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1122 holding.
STRS Ohio first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 13 quarters since.
STRS Ohio's Maravai LifeSciences position peaked at $7.57M in Q4 2021.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.